Axitinib(CAS: 319460-85-0)

Axitinib is a small molecule kinase inhibitor with the chemical formula C15H18N4O2. It is known for its selective targeting of vascular endothelial growth factor (VEGF) receptors, making it a valuable compound in pharmaceutical research. Axitinib is a white to off-white solid at room temperature and has good solubility in organic solvents.

Axitinib is primarily used in the treatment of certain types of cancer, particularly renal cell carcinoma. It functions as a targeted therapy by inhibiting the growth of blood vessels that supply tumors, thereby slowing their progression. Additionally, it is used in research for studying angiogenesis and developing new anticancer drugs.

Axitinib is generally considered safe when used under medical supervision, but it may cause side effects such as hypertension, fatigue, and gastrointestinal issues. Proper handling and adherence to safety guidelines are essential during its use. It is classified as a pharmaceutical compound with established safety standards for therapeutic applications.

Axitinib should be stored in a cool, dry, and dark place, ideally at 20–25°C. It is recommended to keep it in a sealed container to prevent moisture and contamination. Avoid exposure to light and ensure proper ventilation to maintain its stability and efficacy over time.